NanoSyrinx is a synthetic biology company focused on developing a next-generation platform for the targeted intracellular delivery of biological molecules. The company addresses the significant challenge of drug delivery, particularly for biologic drugs like antibodies and peptides, which often struggle to effectively traverse the body. By leveraging over a decade of research, NanoSyrinx aims to revolutionize medicine administration on a nanoscopic scale, utilizing a novel "nanosyringe" platform that can selectively deliver complex biologic payloads directly to the cytosol of targeted cells.

At the heart of NanoSyrinx's technology is a genetically encoded drug delivery system that employs naturally occurring nanosyringes. This innovative approach allows for the engineering of drug delivery vehicles through a straightforward bacterial fermentation process, eliminating the need for cumbersome conjugations or optimization steps. The platform is designed to self-assemble nanosyringes that can deliver a diverse range of protein and peptide payloads, thereby unlocking previously undruggable intracellular therapeutic targets. This capability positions NanoSyrinx to develop safe and effective treatments for a variety of medical needs, marking a significant advancement in the field of intracellular medicine.

United Kingdom

NanoSyrinx is a cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector.

NanoSyrinx

Company Details